Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Pharmacyclics

Lilly drops Hanmi-partnered arthritis drug

Lilly drops Hanmi-partnered arthritis drug

The first BTK inhibitor to reach the market was Johnson &Johnson (J&J) and Pharmacyclics' Imbruvica (ibrutinib), but this has been introduced initially for blood cancers including chronic lymphocytic leukaemia (CLL) ... Meanwhile, Pharmacyclics (now part

Deal Watch March 2017

Deal Watch March 2017 name. (Abexinostat was formerly in development by Pharmacyclics (now owned by AbbVie) and Servier.) Both ACAT-1 (for which Xynomic paid $1.2m upfront with another $59m in potential milestones) and

AbbVie and J&J file first non-cancer use for Imbruvica with FDA

AbbVie and J&J file first non-cancer use for Imbruvica with FDA $21bn it paid to purchase ibrutinib's original developer Pharmacyclics in 2015.

Resurgent Actelion catches J&J's eye

Resurgent Actelion catches J&J's eye That may now be changing, as it was rumoured to have been in the running for Pharmacyclics – eventually bought by AbbVie for $21bn – and said earlier this year it was open

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics